Clinical Laboratory Technology (China) study materials
Clinical Laboratory Technology (China) study resources

Clinical Laboratory Technology (China): Blood cells, morphology and coagulation

Clinical Laboratory Technology (China) · Work through your exam, one topic at a time.

All guide sections

Blood cells, morphology and coagulation

Hematology begins with a suitable specimen, accurate count and interpretable morphology. Anticoagulant, fill, mixing, clots and delay can alter the sample. Automated flags direct review but do not themselves establish a disease. Check the instrument and specimen context, compare relevant prior results and use a well-prepared smear when the procedure requires it.

Red-cell indices express relationships among count, hemoglobin and hematocrit. Mean cell volume, mean cell hemoglobin and mean cell hemoglobin concentration have different units and should be recomputed carefully when a result is implausible. Microcytosis or macrocytosis describes a pattern, not its cause alone. Iron studies, reticulocyte response, hemoglobin analysis and the clinical context can distinguish alternatives. A screening index such as the Mentzer index does not replace confirmatory investigation.

Morphological features can support a lineage or differential. Auer rods support myeloid differentiation, while a classic cell distribution can prompt molecular or flow-cytometric work-up. Cytochemical and immunophenotypic findings are interpreted together with morphology and genetics. A single marker should not be called universally positive in every member of a disease category. Current classifications and qualified diagnostic interpretation matter.

Hemostasis involves platelets, coagulation proteins, endothelium and fibrinolysis. PT and aPTT probe different assay pathways, but an abnormal clotting time is not a direct measure of every bleeding or thrombosis risk. Mixing studies can help distinguish deficiency from inhibition, with incubation, anticoagulant interference and the actual method affecting interpretation. D-dimer reflects degradation of cross-linked fibrin and is not specific for one cause of activation.

Collection quality is essential. A citrate ratio error or markedly unusual hematocrit can affect testing, so the validated collection and adjustment procedure must be followed. The need for a repeat, special test or urgent communication depends on the actual result and context. Do not convert a descriptive blood pattern into an unsupervised transfusion, anticoagulant or chemotherapy decision. This written preparation supports laboratory reasoning and cannot establish competence in specimen collection, microscopy, assay operation or final clinical diagnosis.